A Novel Nitrobenzoate Microtubule Inhibitor that Overcomes Multidrug Resistance Exhibits Antitumor Activity
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Novel Nitrobenzoate Microtubule Inhibitor that Overcomes Multidrug Resistance Exhibits Antitumor Activity
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-08-11
DOI
10.1038/srep31472
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Colchicine: Old and New
- (2015) Anastasia Slobodnick et al. AMERICAN JOURNAL OF MEDICINE
- CCR 20th Anniversary Commentary: BMS-247550--Microtubule Stabilization as Successful Targeted Therapy
- (2015) N. Pabla et al. CLINICAL CANCER RESEARCH
- Eribulin Mesylate: Mechanism of Action of a Unique Microtubule-Targeting Agent
- (2015) N. F. Dybdal-Hargreaves et al. CLINICAL CANCER RESEARCH
- Microtubule-targeting agents are clinically successful due to both mitotic and interphase impairment of microtubule function
- (2014) Jessica J. Field et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial–mesenchymal transition (EMT) to mesenchymal–epithelial transition (MET) states
- (2014) T Yoshida et al. BRITISH JOURNAL OF CANCER
- nab-Paclitaxel in combination with biologically targeted agents for early and metastatic breast cancer
- (2014) Christine Megerdichian et al. CANCER TREATMENT REVIEWS
- Orally active microtubule-targeting agent, MPT0B271, for the treatment of human non-small cell lung cancer, alone and in combination with erlotinib
- (2014) A-C Tsai et al. Cell Death & Disease
- Diversity-oriented synthesis as a tool for identifying new modulators of mitosis
- (2014) Brett M. Ibbeson et al. Nature Communications
- Microtubules and Their Role in Cellular Stress in Cancer
- (2014) Amelia L. Parker et al. Frontiers in Oncology
- Molecular mechanisms of the antitumor activity of SB225002: A novel microtubule inhibitor
- (2013) Ahmed E. Goda et al. BIOCHEMICAL PHARMACOLOGY
- A Novel Synthetic Microtubule Inhibitor, MPT0B214 Exhibits Antitumor Activity in Human Tumor Cells through Mitochondria-Dependent Intrinsic Pathway
- (2013) Nai-Jung Chiang et al. PLoS One
- An NGR-integrated and enediyne-energized apoprotein shows CD13-targeting antitumor activity
- (2012) Yan-bo Zheng et al. BIOMEDICINE & PHARMACOTHERAPY
- Microtubule stabilising agents and ionising radiation: Multiple exploitable mechanisms for combined treatment
- (2012) Carla Rohrer Bley et al. EUROPEAN JOURNAL OF CANCER
- An Overview of Tubulin Inhibitors That Interact with the Colchicine Binding Site
- (2012) Yan Lu et al. PHARMACEUTICAL RESEARCH
- A Bispecific Enediyne-Energized Fusion Protein Containing Ligand-Based and Antibody-Based Oligopeptides against Epidermal Growth Factor Receptor and Human Epidermal Growth Factor Receptor 2 Shows Potent Antitumor Activity
- (2010) X. f. Guo et al. CLINICAL CANCER RESEARCH
- Colchicine poisoning: the dark side of an ancient drug
- (2010) Yaron Finkelstein et al. CLINICAL TOXICOLOGY
- Microtubule-binding agents: a dynamic field of cancer therapeutics
- (2010) Charles Dumontet et al. NATURE REVIEWS DRUG DISCOVERY
- Novel Microtubule Polymerization Inhibitor with Potent Antiproliferative and Antitumor Activity
- (2009) S. Arora et al. CANCER RESEARCH
- Significantly Longer Progression-Free Survival Withnab-Paclitaxel Compared With Docetaxel As First-Line Therapy for Metastatic Breast Cancer
- (2009) William J. Gradishar et al. JOURNAL OF CLINICAL ONCOLOGY
- Mechanisms of drug combinations: interaction and network perspectives
- (2009) Jia Jia et al. NATURE REVIEWS DRUG DISCOVERY
- Overcoming Drug Resistance in Patients with Metastatic Breast Cancer
- (2009) Serena T Wong et al. PHARMACOTHERAPY
- N-(2,6-Dimethoxypyridine-3-yl)-9-Methylcarbazole-3-Sulfonamide as a Novel Tubulin Ligand against Human Cancer
- (2008) Y.-M. Wang et al. CLINICAL CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More